Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.
Pandoraea is a recently classified genus primarily isolated from the sputum of cystic fibrosis patients, but its pathogenic potential is unknown. We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients.
Johnson
Lindsey N
LN
Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Han
Jin-Young
JY
Moskowitz
Samuel M
SM
Burns
Jane L
JL
Qin
Xuan
X
Englund
Janet A
JA
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D020562:Betaproteobacteria / Q000302:isolation & purification*; D019121:Burkholderia Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents